Citeline Podcasts

Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages

09 Feb 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss the issues and concerns raised during a major generic industry conference (:42), former FDA Commissioner Scott...

China Biotech Podcast (Chinese and English Language) - February 2024

08 Feb 2024

Contributed by Lukas

Brian Yang, Dexter Yan and UK-based Kevin Grogan discuss Shanghai's new policy, draft US Biosecure bill, and multinationals AstraZeneca and Sanofi exe...

혁신 육성 전략에 기반한 한국의 제약바이오 강국 야망 (Korean-language podcast)

07 Feb 2024

Contributed by Lukas

박민수 보건복지부 2차관은 Citeline의 Pink Sheet과의 인터뷰에서 정부의 혁신적 R&D 우선순위와 이같은 목표 달성을 위...

Trio Of Diagnostics Execs Weigh In On Upcoming Challenges

06 Feb 2024

Contributed by Lukas

During this episode, Barnaby Pickering is joined by Rollie Carlson, CEO of Immunexpress, developer of Septicyte, a test for sepsis, Mark McDonough, CE...

China Biotech Podcast - Interview With BeiGene Co-Founder Xiaodong Wang

06 Feb 2024

Contributed by Lukas

Xiaodong Wang of major Chinese pharma firm BeiGene and China's National Institute of Biological Sciences shares views on China biotech innovation, Bei...

Title: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate

05 Feb 2024

Contributed by Lukas

HBW Insight continues its conversation with The Exponential Club’s Nick Tate. In this episode, we discuss what the future of consumer health might a...

Scrip's Five Must-Know Things - 5 February 2024

05 Feb 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: the biggest drug launches expected in 20...

Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App

30 Jan 2024

Contributed by Lukas

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with industry leaders in medtech and healthtech and de...

Automating Cell Therapy Manufacturing: Cellular Origins' CEO Talks Robotics

29 Jan 2024

Contributed by Lukas

In the latest episode of the In Vivo podcast, Edwin Stone, CEO of UK-based Cellular Origins, talks about how robotics can increase access to safe cell...

Scrip's Five Must-Know Things - 29 January 2024

29 Jan 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s pipeline refresh; J&J’s sele...

Medtech Connect Episode 12: Apple’s Patent Infringement Cases

26 Jan 2024

Contributed by Lukas

Medtech Insight regulatory reporter Hannah Daniel speaks to Sanjay Voleti, AliveCor’s chief business officer, about his company’s patent infringem...

Drug Fix: Janet Woodcock And The US FDA’s G.O.A.T., Puberty Blockers Meeting, CAR-T Safety

26 Jan 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss FDA Principal Deputy Commissioner Janet Woodcock’s place in the pantheon of FDA leaders (:27), an agency mee...

Q&A Session on Treatment of LBCL With Oncologist Donald Fleming, MD

22 Jan 2024

Contributed by Lukas

In this discussion, Dr. Fleming provides expert insight to questions about treating LBCL in elderly patients and those with comorbidities.

The Promise Of AI For Consumer Health, Pt 1, With The Exponential Club’s Nick Tate

22 Jan 2024

Contributed by Lukas

In this episode, HBW Insight speaks to The Exponential Club’s Nick Tate about the impact of artificial intelligence and digitalization on consumer h...

Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals

19 Jan 2024

Contributed by Lukas

Pink Sheet reporters and editors discuss the nearly wide open 2024 FDA advisory committee calendar, CMS’s impact on Florida’s drug importation pla...

China Biotech Podcast - Major Takeaways From JPM (January 2024 - Chinese-Language)

19 Jan 2024

Contributed by Lukas

VelaVigo founder and CEO Jing Li in Shanghai joins guest speaker Leon Tang in the US and Brian Yang in Beijing to discuss what stood out in this speci...

【3分で解説 世界のファーマ】第16回 JPモルガンで見えた2024年の製薬業界 (Japanese-language podcast)

19 Jan 2024

Contributed by Lukas

（日本語版）今回取り上げた記事はこちら 「J.P. Morgan 2024: Optimism With An Undercurrent Of Tension（J.P.モルガン2024年：緊...

Scrip's Five Must-Know Things - 15 January 2024

15 Jan 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: major takeaways and highlights from the ...

Pennine Health Talks Sustainability Compliance and ESG Initiatives

12 Jan 2024

Contributed by Lukas

Pennine Health Talks Sustainability Compliance and ESG Initiatives by Citeline

Drug Fix: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI

12 Jan 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss a new pilot project allowing collaborative reviews of gene therapies by multiple regulators (:42), predictions...

Building A Biotech: Exploring ILC’s Hybrid Interferon Platform

11 Jan 2024

Contributed by Lukas

In the latest episode of the In Vivo podcast, non-executive chair Peter Bains and Owain Millington, vice president of immunology and head of preclinic...

전 세계 비만 치료제 임상시험 건 수, 미국이 가장 높아…한국은 9위 (Korean-language podcast)

11 Jan 2024

Contributed by Lukas

Join Jung Won Shin for this Korean-language mini podcast talking about a report from Citeline's Datamonitor Healthcare. Datamonitor Healthcare의 비...

Scrip's Five Must-Know Things - 10 January 2024

10 Jan 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: 2023 drug launch highlights; the M&A out...

Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions

09 Jan 2024

Contributed by Lukas

Listen as Chris Smyth, President, ICON Biotech Solutions discusses current trends in the biotech landscape, and predictions for future innovation, reg...

China Biotech Podcast - January 2024 (Chinese-language)

09 Jan 2024

Contributed by Lukas

One week into 2024, there have already been multiple deals between Chinese innovative drug developers and multinational and the significant acquisitio...

Cardio Conversations: AVS Cracks Calcium With Novel Pressure Wave Balloon

05 Jan 2024

Contributed by Lukas

In this edition of Cardio Conversations, Medtech Insight editor Reed Miller talked to Robert Chisena, the co-founder and CTO of AVS. He talked about t...

Drug Fix: Looking Back And Looking Ahead: Key US and EU Legislation

05 Jan 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss key US and EU legislation that impacted 2023 and how it also could affect 2024, including EU legislative refor...

Unlock the Future of Cancer Detection with Dr Charles P. Vega, MD, FAAFP: Listen Now!

03 Jan 2024

Contributed by Lukas

Join us for an insightful Q&A session with Dr. Vega, where we delve into the groundbreaking world of Multi-Cancer Early Detection (MCED) and the futur...

The Challenges of Rare Neurological Disease Drug Development

22 Dec 2023

Contributed by Lukas

In this episode, In Vivo speaks to Bruce Leuchter, CEO of Neurvati Neurosciences, about ways clinical drug development in rare neurologic diseases is ...

【3分で解説 世界のファーマ】第15回 治験に被験者の「多様性」を 米国の課題 (Japanese-language podcast)

22 Dec 2023

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Medtech Connect Episode 11: A Look Back At 2023

20 Dec 2023

Contributed by Lukas

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to King & Spalding’s Eric Henry about the year’s most influential digita...

Biopharma’s Must-Know 2023-4 Catalysts

20 Dec 2023

Contributed by Lukas

In this podcast Scrip looks at the some upcoming clinical catalysts for biopharma, judged by the size of the sales forecasts at stake. Companies inclu...

Scrip’s Five Must-Know Things – 19 December 2023

19 Dec 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: first ever gene editing FDA nod; US FTC ...

Drug Fix: Taking A Look Back, And Forward, With US FDA’s Project Orbis

15 Dec 2023

Contributed by Lukas

Pink Sheet reporters and editors in the US and Europe consider the growth and impact of Project Orbis after a year in which two major regulators joine...

China Biotech Podcast - December 2023 (Chinese-language)

14 Dec 2023

Contributed by Lukas

Brian Yang and Dexter Yan discuss Biokin/BMS's ADC deal, WuXi Biologics' share price drop, BlissBio's recent developments and Pfizer's divestment of P...

Scrip’s Five Must-Know Things – 11 December 2023

11 Dec 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: another acquisition for AbbVie; Roche bu...

Over the Counter 7 Dec 2023: IFRA On Potential Impact Of EU's CLP Revision

07 Dec 2023

Contributed by Lukas

In this episode, HBW Insight speaks to Aurélie Perrichet, regional director, Europe at the International Fragrance Association. We discussed the impl...

제약업계의 생성형AI 적용 성공의 열쇠는? (Korean-language podcast)

05 Dec 2023

Contributed by Lukas

최근 제프리스 헬스케어 컨퍼런스에서 발표된 제약바이오산업의 생성형인공지능 적용사례에 대한 Scrip 기사를 요...

Scrip's Five Must-Know Things - 4 December 2023

04 Dec 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: CAR-Ts and malignancies; comeback for GS...

Drug Fix: CAR-T Malignancy Reports, Background Music In DTC Ads, New No. 2 At US FDA

01 Dec 2023

Contributed by Lukas

Pink Sheet reporter and editors discuss the FDA acknowledging reports of malignancies in patients who received CAR-T cell immunotherapies (:35), the a...

RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering

27 Nov 2023

Contributed by Lukas

In this podcast, In Vivo speaks to Sara Barrington, CEO of Verici DX. During the discussion, Barrington outlines the current challenges facing patient...

Scrip’s Five Must-Know Things – 27 November 2023

27 Nov 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s Phase III failure; US group se...

Trends In Epidemiology

23 Nov 2023

Contributed by Lukas

Datamonitor Healthcare’s Epidemiology team (Ridwaan Ibrahim, Lucia Rodriguez-Garcia, Maya Trivedy, and Asma Ali) discuss the current trends in epide...

Scrip Lifetime Achievement Award 2023: Jeremy Levin’s Acceptance Speech

22 Nov 2023

Contributed by Lukas

In accepting Scrip’s Lifetime Achievement Award, Ovid Therapeutics’ CEO called on pharma to show responsible leadership and live up to its potenti...

China Biotech Podcast (Chinese language) - November 2023

21 Nov 2023

Contributed by Lukas

Brian Yang and Dexter Yan discuss the FDA approval of Chinese PD-1, Sanofi BioMap AI deal, Third quarter earnings and Biden-Xi Summit and US-China reg...

Discussing The Potentials Of And Challenges For Digital Therapeutics

21 Nov 2023

Contributed by Lukas

In this podcast, Medtech Insight speaks to Andy Molnar, CEO of the digital therapeutics alliance; Joel Morse, CEO and co-founder of Curavit and Owen M...

Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology

21 Nov 2023

Contributed by Lukas

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with Abbott’s head of Lingo Biowearables and top exe...

Scrip’s Five Must-Know Things – 20 November 2023

20 Nov 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: AstraZeneca CEO on obesity and more; bio...

Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy

17 Nov 2023

Contributed by Lukas

Pink Sheet reporters and editors discuss US FDA Principal Deputy Commissioner Janet Woodcock’s legacy as her retirement approaches (:42), the stance...

Syngene CEO On Sub-Dynamics As US Biotech Funding Finds New Normal, ADC Capabilities

17 Nov 2023

Contributed by Lukas

Syngene’s MD & CEO, Jonathan Hunt, in an interview with Scrip, dissects trends and opportunities in the CRDMO segment as US biotechs slow their burn...

Scrip’s Five Must-Know Things – 13 November 2023

13 Nov 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US approval for Lilly’s obesity drug; ...

Drug Fix: FTC Orange Book Patent Challenges, Ad/Promo Due Diligence, US FDA Adcomm Decision Appeal

10 Nov 2023

Contributed by Lukas

Pink Sheet reporter and editors discuss the FTC’s challenges of Orange Book patents (:35), DTC promotion practices as part of acquisition due dilige...

How OTC Companies Can Respond To Preventative Health Trends - With Simon Kucher & Partners

10 Nov 2023

Contributed by Lukas

In this episode, HBW Insight speaks to Simon-Kucher & Partners about the latest trends in preventative consumer health. Partner Christian Rebholz and ...

Humira Biosimilar Landscape Podcast

08 Nov 2023

Contributed by Lukas

Humira Biosimilar Landscape Other platforms Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 Goog...

일본 최대 바이오클러스터, 한국 바이오벤처들과 CGT 협업 추진 (Korean-language podcast)

07 Nov 2023

Contributed by Lukas

일본 최대 제약바이오 R&D 허브와 한국 바이오벤처들이 세포유전자치료제 분야의 협업을 활발히 추진하고 있다는...

Scrip’s Five Must-Know Things – 6 November 2023

06 Nov 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: CEOs on global tensions; Roche’s new A...

Drug Fix: CMS Listens On Price Negotiations, Elevidys Top-Line Trial Data, Gene Therapy Reg Changes

03 Nov 2023

Contributed by Lukas

Pink Sheet reporters and editor discuss take-aways from the first Medicare price negotiation program public listening sessions (:35), next steps after...

【3分で解説 世界のファーマ】第14回 承認２カ月後に新薬発売へ、スイスの新制度 (Japanese-language podcast)

02 Nov 2023

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Podcast: Overcoming regulatory challenges in a complex clinical trial landscape

01 Nov 2023

Contributed by Lukas

Listen in as Citeline sits down with a regulatory and compliance expert Mai Mishir, Senior Director, Global Regulatory Affairs from Advanced Clinical....

Biotech CEO Podcast with William Wei Cao of Gracell Bio

01 Nov 2023

Contributed by Lukas

Brian Yang interviews Nasdaq-listed cell therapy developer Gracell Bio Founder and CEO William Wei Cao who discussed the plan to enter the US market t...

China Biotech Podcast (Chinese language) - October 2023

31 Oct 2023

Contributed by Lukas

In this Chinese-language podcast, Brian Yang and Dexter Yan discuss China biotech topics including the annual IND and NDA report from Center for Drug ...

Scrip’s Five Must-Know Things – 30 October 2023

30 Oct 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: did Pfizer miss out on Roivant/Roche dea...

Drug Fix: Off-Label Coms Guidance, Price Negotiations And Prescribing, Bertagnolli’s NIH Bid

27 Oct 2023

Contributed by Lukas

Pink Sheet reporters and editors discuss new off-label use communications guidance (:35), how price negotiations could impact prescribing (9:49), and ...

AI In Behavioral Health Clinics

25 Oct 2023

Contributed by Lukas

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with behavioral health experts on implementing AI solu...

Over The Counter 24 Oct 2023: An Approach To MoCRA With Good Face Project’s Iva Teixeira

24 Oct 2023

Contributed by Lukas

Over The Counter 24 Oct 2023: An Approach To MoCRA With Good Face Project’s Iva Teixeira by Citeline

Scrip’s Five Must-Know Things – 23 October 2023

23 Oct 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Daiichi’s huge ADC deal with Merck; mi...

Drug Fix: BrainStorm Withdraws NurOwn, NIH Nominee On Drug Pricing, Gene Therapy Long-Term Follow-Up

20 Oct 2023

Contributed by Lukas

Pink Sheet reporters and editor discuss BrainStorm’s next steps after withdrawing the NurOwn BLA (:38), NIH director nominee Monica Bertagnolli’s ...

Medtech Insight: The Realities Of Real-World Evidence.

18 Oct 2023

Contributed by Lukas

n this special podcast, Medtech Insight managing editor Elizabeth Orr talks to consultant Steve Silverman about the FDA’s current position on real-w...

Q&A with Dr. Marc Sandberg: A Specialist in Endocrinology, Diabetes & Metabolism

18 Oct 2023

Contributed by Lukas

Q&A with Dr. Marc Sandberg: A Specialist in Endocrinology, Diabetes & Metabolism by Citeline

Centrient Delivers Innovation In Biotechnology

17 Oct 2023

Contributed by Lukas

Listen as executives from Centrient Pharmaceuticals share insider perspectives on innovations in sustainable, efficient, clean manufacturing practices...

Q&A with Sleep Medicine Specialist Nathaniel Watson, MD

16 Oct 2023

Contributed by Lukas

Q&A with Sleep Medicine Specialist Nathaniel Watson, MD by Citeline

Scrip’s Five Must-Know Things – 16 October 2023

16 Oct 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: BMS buys Mirati; slow Q3 for biopharma M...

Drug Fix: US FDA Suffers From Shutdown Threat, Alnylam’s CR Letter, ARPA-H Wants FDA Incentives

13 Oct 2023

Contributed by Lukas

Pink Sheet reporters and editor discuss the problems that emerged for the US FDA from just the threat of a government shutdown (:38), take-aways on th...

Scrip’s Five Must-Know Things – 11 October 2023

11 Oct 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Lilly’s radiopharmaceutical buy; stron...

아일랜드, 글로벌 제약사의 투자처로 각광 (Korean-language podcast)

09 Oct 2023

Contributed by Lukas

릴리, 다케다, 아스트라제네카에 이어 MSD, 아스텔라스도 아일랜드에 대규모 투자 동참 https://scrip.citeline.com/SC14904...

What’s Going On With Oral Phenylephrine In The US? With HBW’s Malcolm Spicer

06 Oct 2023

Contributed by Lukas

In this episode, HBW Insight speaks to its own OTC expert, managing editor Malcom Spicer, about recent controversy in the US surrounding oral nasal de...

Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies

04 Oct 2023

Contributed by Lukas

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to Washington Analysis vice president and senior healthcare analyst John Lep...

Scrip’s Five Must-Know Things – 3 October 2023

03 Oct 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: major Q4 catalysts; Verona’s COPD cont...

Scrip M&A Podcast: US FTC Review of Mergers and Acquisitions

02 Oct 2023

Contributed by Lukas

Scrip writers Joseph Haas and Jessica Merrill discuss US FTC overview of biopharma mergers like Amgen/Horizon and Pfizer/Seagen with Leerink Partners'...

Drug Fix: Adcomm Rejects NurOwn For ALS, FDA In Shutdown Mode, Limited Price Negotiation Savings

29 Sep 2023

Contributed by Lukas

Pink Sheet reporters and editors consider the fallout from Brainstorm Cell Therapeutics Inc.’s negative US FDA advisory committee decision on its AL...

Scrip’s Five Must-Know Things – 28 September 2023

28 Sep 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Novartis gives back Beigene PD-1; BMS re...

Disrupting the Consumer Health Industry, With Maxwellia’s Anna Maxwell

25 Sep 2023

Contributed by Lukas

In this episode, HBW Insight catches up with UK switch specialists Maxwellia to find out what’s next for the company that gave to the UK one of the ...

Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart

25 Sep 2023

Contributed by Lukas

Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biol...

Scrip’s Five Must-Know Things – 20 September 2023

20 Sep 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Biomarin’s next chapter; Amgen’s obe...

Drug Fix: Regeneron’s COVID Monoclonal Deal, New FDA Advisor, Project Optimus In Cancer Combos

15 Sep 2023

Contributed by Lukas

Pink Sheet reporter and editors discuss the somewhat novel pricing language in Regeneron’s deal with the US government to develop a COVID-19 monoclo...

Scrip’s Five Must-Know Things – 13 September 2023

13 Sep 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: the rise of Novo Nordisk; senior level c...

Trends Shaping The OTC Industry Today, With BSS Consulting’s Birgit Schuhbauer

11 Sep 2023

Contributed by Lukas

In the second part of HBW Insight’s exclusive interview with OTC industry veteran Birgit Schuhbauer, we discuss the trends that will shape the futur...

지피지기면 백전백승” 대웅이노베이션의 미국시장 전략 (Korean-language podcast)

11 Sep 2023

Contributed by Lukas

어동규 대웅이노베이션홀딩스 대표의 Scrip Intelligence 인터뷰 기사를 요약한 내용입니다 https://scrip.citeline.com/SC1487...

Drug Fix: FTC Ends Amgen-Horizon Case, New Ultra-Rare Cancer Partnership, Generic Applications Lag

08 Sep 2023

Contributed by Lukas

Pink Sheet reporter and editors discuss the US Federal Trade Commission ending its attempt to block the Amgen acquisition of Horizon Therapeutics (:28...

Medtech Connect Episode 9: The Intersection Of IVDs And Digital Health

07 Sep 2023

Contributed by Lukas

In this episode, Medtech Insight regulatory reporter Hannah Daniel and managing editor Amanda Maxwell speak to Marcel Gehrung, co-founder and CEO of C...

Dr Reddy’s MD On The Next Horizon, Owner-Managed Firms, Life Lessons From Birds

07 Sep 2023

Contributed by Lukas

Dr Reddy's Laboratories' co-chairman and managing director, G V Prasad, talks with Scrip’s Anju Ghangurde about his conversations with late founder ...

Creating A Digital Biotech Story

06 Sep 2023

Contributed by Lukas

In this latest instalment of the In Vivo podcast Daniel Lofaso, CEO of Digital Elevator, talks about the common mistakes biotech companies make when t...

Scrip’s Five Must-Know Things – 4 September 2023

04 Sep 2023

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US Medicare price negotiations get soft ...

Digital Health Roundup: VR, AI Trends In Rehabilitation; Cybersecurity Regulations; Medicare Updates

01 Sep 2023

Contributed by Lukas

Summary: In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights VR, AI and other high tech trends in rehabilitation and...

Drug Fix: What We Learned From The First Medicare Price Negotiation List, Pepaxto Withdrawal Update

01 Sep 2023

Contributed by Lukas

Pink Sheet reporters and editors consider lessons and next steps after the first list of drugs subject to Medicare price negotiations was released (:3...

China Biotech CEO Interview with Hua Medicine’s Li Chen

01 Sep 2023

Contributed by Lukas

Hua Medicine’s founder and CEO Li Chen discusses with host Brian Yang about its new product launch for dorzagliatin, glucokinase activator for type ...

Emergex CEO Questions mRNA Vaccines Against ‘Wuhan Virus’, Works On Universal Vaccines

31 Aug 2023

Contributed by Lukas

Scrip’s senior editor Vibha Ravi speaks with Dr Thomas Rademacher, Emergex CEO and ex-research director at the University of Oxford, about the myth ...

Podcast: Operationalizing Decentralized Clinical Trials

30 Aug 2023

Contributed by Lukas

Listen in as experts from Advanced Clinical discuss the evolution of the decentralized clinical trial model and what it means in a post-COVID landscap...

How To Be A Consumer Health Leader, With BSS Consulting’s Birgit Schuhbauer

29 Aug 2023

Contributed by Lukas

In this episode, HBW Insight talks to BSS Consulting’s Birgit Schuhbauer about her stellar career in consumer healthcare. Up until recently, Schuhba...

Fourth Time Lucky: How Mithra’s Novel Estrogen E4 Is Disrupting The Women’s Health Market

29 Aug 2023

Contributed by Lukas

Mithra is shaking up the stagnant women’s health market with a brand new estrogenic compound. E4, or estetrol, is a natural estrogen produced by the...